Through a pilot randomized controlled trial (RCT), we aim to test the feasibility and preliminary impact of two online pain educations programs among adult patients with inflammatory bowel disease (IBD) who experience chronic pain. Each online program can be accessed on the patient's personal device, and will take about 2 hours to complete. Clinical outcomes (pain intensity, pain interference, quality of life) will be assessed via online surveys at baseline and then weekly for 8-weeks post-treatment.
Physician-confirmed diagnosis of Crohn's disease or ulcerative colitis
Chronic pain (visceral and/or somatic) related to IBD for at least 3 months
NIH PROMIS Pain Interference scale T-score ≥60
No acute IBD-related hospitalization within the past 3 months; AND
Cognitive impairment or other condition that, in the opinion of the investigators, would interfere with protocol participation
Current use of standing opioid medications, given the often severe impact of opioids on GI motility and potential for pharmacological visceral hyperalgesia
Prior participation in cognitive behavioral therapy (CBT) specifically targeting chronic IBD-related pain